IB 

Union Calendar No. 592 

115TH CONGRESS 

2D SESSION H. R. 5723 

[Report No. 115–760, Part I] 

To require the Medicare Payment Advisory Commission to report on opioid 

payment, adverse incentives, and data under the Medicare program. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 9, 2018 

Ms. TENNEY (for herself, Mr. MCKINLEY, and Ms. DELBENE) introduced the 

following bill; which was referred to the Committee on Ways and Means, 

and in addition to the Committee on Energy and Commerce, for a period 

to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee 

concerned 

JUNE 19, 2018 

Additional sponsors: Mr. RENACCI and Mr. SANFORD

JUNE 19, 2018 

Reported from the Committee on Ways and Means with an amendment 

[Strike out all after the enacting clause and insert the part printed in italic] 

JUNE 19, 2018 

Committee on Energy and Commerce discharged; committed to the Committee 

of the Whole House on the State of the Union and ordered to be printed 

[For text of introduced bill, see copy of bill as introduced on May 9, 2018] 


amozie on DSK3GDR082PROD with BILLS
2 

•HR 5723 RH

A BILL 

To require the Medicare Payment Advisory Commission to 

report on opioid payment, adverse incentives, and data 

under the Medicare program. 


amozie on DSK3GDR082PROD with BILLS
3 

•HR 5723 RH

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Expanding Oversight 

5 of Opioid Prescribing and Payment Act of 2018’’. 

6 SEC. 2. MEDICARE PAYMENT ADVISORY COMMISSION RE7 PORT ON OPIOID PAYMENT, ADVERSE INCEN8 TIVES, AND DATA UNDER THE MEDICARE 

9 PROGRAM. 

10 Not later than March 15, 2019, the Medicare Payment 

11 Advisory Commission shall submit to Congress a report on, 

12 with respect to the Medicare program under title XVIII of 

13 the Social Security Act, the following: 

14 (1) A description of how the Medicare program 

15 pays for pain management treatments (both opioid 

16 and non-opioid pain management alternatives) in 

17 both inpatient and outpatient hospital settings. 

18 (2) The identification of incentives under the 

19 hospital inpatient prospective payment system under 

20 section 1886 of the Social Security Act (42 U.S.C. 

21 1395ww) and incentives under the hospital outpatient 

22 prospective payment system under section 1833(t) of 

23 such Act (42 U.S.C. 1395l(t)) for prescribing opioids 

24 and incentives under each such system for prescribing 

25 non-opioid treatments, and recommendations as the 


amozie on DSK3GDR082PROD with BILLS
4 

•HR 5723 RH

1 Commission deems appropriate for addressing any of 

2 such incentives that are adverse incentives. 

3 (3) A description of how opioid use is tracked 

4 and monitored through Medicare claims data and 

5 other mechanisms and the identification of any areas 

6 in which further data and methods are needed for im7 proving data and understanding of opioid use. 


amozie on DSK3GDR082PROD with BILLS

amozie on DSK3GDR082PROD with BILLS
Union Calendar No. 592 

115TH CONGRESS 

2D SESSION H. R. 5723 

[Report No. 115–760, Part I] 

A BILL 

To require the Medicare Payment Advisory Comcentives, and data under the Medicare program. mission to report on opioid payment, adverse inJUNE 19, 2018 

Reported from the Committee on Ways and Means with 

J

an amendment 

UNE 19, 2018 

Committee on Energy and Commerce discharged; comState of the Union and ordered to be printed mitted to the Committee of the Whole House on the 


amozie on DSK3GDR082PROD with BILLS